Robert C. Robbins, M. D.
Key Documents
Contact Information
-
Clinical Offices
Cardiothoracic Surgery Clinic 300 Pasteur Dr Falk CVRB ULN MC:5407 Stanford, CA 94305 Tel Work (650) 725-6954 Fax (650) 725-3846
- Academic Offices
Personal Information EmailAdministrative Contact Beverly Bonfert Administrative Associate Email Tel Work (650) 725-3828Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Heart and Lung Transplantation
- Cardiothoracic Surgery
- Thoracic Surgery
Administrative Appointments
- Chair,Department of Cardiothoracic Surgery Director,Stanford Cardiovascular Institute, Stanford University School of Medicine (2005 - present)
Professional Education
| Residency: | Univ Of Mississippi Med Ctr MS (1989) |
| Residency: | Univ Of Mississippi Med Ctr MS (1985) |
| Residency: | Stanford University School of Medicine CA (1992) |
| Board Certification: | Thoracic Surgery, American Board of Thoracic Surgery (1994) |
| Board Certification: | General Surgery, American Board of Surgery (1990) |
| Fellowship: | Columbia Presbyterian Medical Center NY (1985) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
1. The investigation of the immunobiology and factors associated with the in vivo survival of mouse and human embryonic stems used for the treatment of congestive heart failure.
2. The study of genetic determinants of congestive heart failure.
3. Hemodynamic, MRI, Echocardiographic, and Molecular Imaging assessment of congestive heart failure and cell therapy in mice and rats.
4. The investigation of Apelin in congestive heart failure.
5. The study of the role of bcl-2 in cardiac allograft vasculopathy.
6. The development of automated coronary anastomotic devices.
7. The assessment of tissue engineered blood vessels.
Publications
- Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; (6983): 668-73
- Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell. 2013; (1): 101-13
- Change you can count on. J Thorac Cardiovasc Surg. 2013; (2): 321-5
- Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation. 2013; (16): 1677-91
- Heart transplant graft survival is improved after a reduction in panel reactive antibody activity. J Thorac Cardiovasc Surg. 2013; (2): 555-64; discussion 564-5
- The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease. Transplantation. 2013; (2): 285-92
Help